Details for Patent: 9,259,403

Title:	Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide
Abstract:	The present invention relates to novel crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide. Processes for the preparation of this form, compositions containing the form, and methods of use thereof are also described.
Inventor(s):	Surana; Rahul (Coram, NY), Dedhiya; Mahendra G. (Pomona, NY)
Assignee:
Filing Date:	Oct 20, 2014
Application Number:	14/518,300
Claims:	1. A crystalline form of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide having an X-ray powder diffraction pattern comprising characteristic peaks at 12.0, 20.1 and 22.5.+-.0.2 degrees 2.theta.. 2. The crystalline form of claim 1, wherein the X-ray powder diffraction pattern further comprises a characteristic peak at 32.7.+-.0.2 degrees 2.theta.. 3. The crystalline form of claim 1, wherein the X-ray powder diffraction pattern further comprises a characteristic peak at 6.0.+-.0.2 degrees 2.theta.. 4. A pharmaceutical composition comprising the crystalline form of claim 1 and a pharmaceutically acceptable carrier. 5. A method of treating a disorder that can be managed by inhibition of norepinephrine and serotonin reuptake in a patient in need thereof, by administering to said patient an effective amount of a pharmaceutical compositions that comprises the crystalline form of claim 1. 6. A process for preparing the crystalline form of claim 1, comprising dissolving (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide and precipitating the crystalline form.